Archive · 15 Sep 2025
Higher Semaglutide Dose Safe, Boosts Weight Loss: Study
Scientists tested a higher dose (7.2mg) of the weight loss medicine semaglutide.
The study showed it helps people lose more weight than the usual dose.
The trials included adults with and without diabetes.
Many people lost weight, and their health improved, such as lower blood sugar and blood pressure.
The higher dose was generally safe, with manageable side effects.
This could be a new option for people struggling with obesity and diabetes.
A higher dose of semaglutide (7.2 mg) was tested in international clinical trials.
The trials included adults with and without type 2 diabetes.
The 7.2 mg dose led to greater weight loss compared to lower doses and placebos.
Participants also saw improvements in health markers like blood sugar and blood pressure.
The higher dose was generally safe, with manageable side effects.
- Who
- Researchers in international clinical trials
- What
- Studied a higher dose of semaglutide for weight loss
- When
- Published on Monday
- Where
- International clinical trials
- Why
- To determine if a higher dose of semaglutide leads to greater weight loss and improved health outcomes.
- Drug Name
- Semaglutide
- Dosage Tested
- 7.2 mg
- Study Type
- Phase 3 Clinical Trials
- Participants
- International adults with/without type 2 diabetes
- Weight Loss (Adults w/o Diabetes)
- Average 19%
- Weight Loss (Adults w/ Diabetes)
- Average 13%
- Common Side Effects
- Nausea, diarrhea, tingling
Sources
Fighting the obesity challenge: Lancet study says higher doses of weight loss drugs can safely reduce body weight faster
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
Higher Doses of Semaglutide are Safe, More Effective for Weight Loss in Obese Adults, Says Lancet Study
